• Sigma Lithium Corporation recently reported full-year 2025 results, with sales of US$110.01 million versus US$151.35 million in 2024 and a net loss of US$50.19 million, while also issuing multi-year production guidance through 2028.
• An interesting takeaway is that, despite lower sales and continuing losses, Sigma Lithium laid out a phased plan to lift output from 240,000 tonnes in 2026 to 770,000 tonnes by 2028, signaling a clear focus on scaling operations.
• We’ll now examine how Sigma Lithium’s new multi-year production guidance could reshape its investment narrative and outlook on future growth.

Outshine the giants: these 21 early-stage AI stocks could fund your retirement.

Sigma Lithium Investment Narrative Recap

To own Sigma Lithium, you need to believe the company can turn its Brazil-based lithium resource and Greentech plant into a profitable, scalable operation despite current losses. The latest 2025 results, with lower sales and a US$50.19 million net loss, do not materially change the near term focus on proving reliable production and securing attractive offtake terms, while the biggest risk remains exposure to lithium price swings and the timing of selling its output.

The new 2026 to 2028 production guidance is the most relevant update here, because it ties directly into that execution and pricing risk. A plan to ramp from 240,000 tonnes in 2026 to 770,000 tonnes in 2028 strengthens the capacity growth story but also raises the stakes around funding, offtake progress and the company’s ability to manage earnings volatility as volumes grow.

Yet beneath this expansion story, investors should still be aware of the company’s sensitivity to lithium price cycles and...

Sigma Lithium's narrative projects $600.1 million revenue and $57.4 million earnings by 2028.

Uncover how Sigma Lithium's forecasts yield a $17.17 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were penciling in roughly US$535 million of revenue and US$419 million of earnings by 2028, which contrasts sharply with current losses and highlights how views on Sigma’s execution and pricing risk can differ widely, especially if production delays or financing constraints start to challenge those assumptions.

Explore 4 other fair value estimates on Sigma Lithium - why the stock might be worth just $15.00!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Sigma Lithium research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Sigma Lithium research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sigma Lithium's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.